Impact of the Covid-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada
A population-based time-series analysis
Datos Bibliográficos
| ID | 14908960 |
|---|---|
| Autores | Sophie A Kitchen (0000-0002-2910-2428, autor de correspondencia), Tonya Campbell (0000-0001-8459-208X, St. Michael's Hospital), Siyu Men, Nikki Bozinoff (0000-0001-9512-7407, Centre for Addiction and Mental Health), Mina Tadrous (0000-0003-1911-6129, Women's College Hospital), Tony Antoniou (0000-0002-6984-8953, St. Michael's Hospital), Jennifer Wyman (Women's College Hospital), Dan Werb (0000-0003-0614-9386, St. Michael's Hospital), Charlotte Munro (0000-0003-1911-7586, Ontario Stroke Network), Thayse Gomes (0000-0002-1468-1965, St. Michael's Hospital) |
| Año | 2022 |
| Volumen | 103 |
| Páginas | 103644 |
| Fecha de publicación | 2022-05-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2022.103644 |
| PMID | 35272107 |
| OpenAlex | W4214697512 |
| Idioma | EN |
| Citas recibidas | 12 |
| Referencias citadas | 13 |
Anesthesia · Buprenorphine · Coronavirus disease 2019 (COVID-19 · Environmental health · Methadone · Opioid · Pandemic · Population · HIV, Drug Use, Sexual Risk · Medicine · Opioid Use Disorder Treatment · Substance Abuse Treatment and Outcomes · Emergency Medicine · Internal Medicine
Impact of guidance issued during Covid-19 to expand access to take-home dosing of opioid agonist treatment (OAT) on OAT prescribing practices in primary care in Ireland
An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions
Impacts of the Covid-19 pandemic on enrollment in medications for opioid use disorder (Moud) in Vancouver, Canada
Drug treatment and support service utilization amidst the Covid-19 pandemic among people who inject drugs in Baltimore, Maryland
Patterns of opioid toxicity deaths after the implementation of Covid-19 emergency measures in Ontario, Canada
Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during Covid-19 pandemic restrictions
Public transport access to drug treatment before and during Covid-19
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the Covid-19 pandemic in England
Consensus recommendations for opioid agonist treatment following the introduction of emergency clinical guidelines in Ireland during the Covid-19 pandemic
Trends in use of medicines for opioid agonist treatment in Australia, 2013–2022
Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD)
Established Tables and Emergent Huddles
Interrupted time series analysis using autoregressive integrated moving average (Arima) models
Mortality risk during and after opioid substitution treatment
Retention in medication-assisted treatment for opiate dependence
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
| Obras citantes distintas | 12 |
|---|---|
| Citas por año | 3 |
| Intervalo de citas | 2022 - 2026 (5) |
| Velocidad de citación | current |
| Altamente citado | No |
| Tipos de cita | Neutras: 12 |